Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers
European Journal of Pharmacology · 2023-12 · 960 · 176103
DOI: 10.1016/j.ejphar.2023.176103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2023-12. Verfasst von Xinxin Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China; Xiangnan …. Hauptthemen laut MEDLINE: Mast Cells, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: Education Department of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mast cell is an important cellular component that plays a crucial role in the crosstalk between innate and adaptive immune responses within the tumor microenvironment (TME). Recently, numerous studies have indicated that mast cells related to tumors play a dual role in regulating cancers, with conflicting results seemingly determined by the degranulation medium. As such, mast cells are an ignored but very promising potential target for cancer immunotherapy based on their immunomodulatory function. In this review, we present a comprehensive overview of the roles and mechanisms of mast cells in diverse cancer types. Firstly, we evaluated the infiltration density and location of mast cells on tumor progression. Secondly, mast cells are activated by the TME and subsequently release a range of inflammatory mediators, cytokines, chemokines, and lipid products that modulate their pro-or anti-tumor functions. Thirdly, activated mast cells engage in intercellular communication with other immune or stromal cells to modulate the immune status or promote tumor development. Finally, we deliberated on the clinical significance of targeting mast cells as a therapeutic approach to restrict tumor initiation and progression. Overall, our review aims to provide insights for future research on the role of mast cells in tumors and their potential as therapeutic targets for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China; Xiangnan University, Chenzhou, China.
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China. Electronic address: ranliu@seu.edu.cn.
Förderung
- Education Department of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Guo, X., Sun, M., Yang, P., Meng, X., & Liu, R. (2023). Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers. European Journal of Pharmacology, 960, 176103. https://doi.org/10.1016/j.ejphar.2023.176103
Vancouver
Guo X, Sun M, Yang P, Meng X, Liu R. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers. European Journal of Pharmacology. 2023;960:176103. doi:10.1016/j.ejphar.2023.176103
BibTeX
@article{Guo2023,
author = {Guo, Xinxin and Sun, Mingjun and Yang, Peiyan and Meng, Xingchen and Liu, Ran},
title = {Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers},
journal = {European Journal of Pharmacology},
year = {2023},
volume = {960},
pages = {176103},
doi = {10.1016/j.ejphar.2023.176103}
}
EUVIMED